Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · International Flavors & Fragrances (IFF)

IFF: President of Health & Biosciences Simon Herriott to leave March 31, 2025

Neutral Impact 3 of 5 leadership Written later

IFF said Simon Herriott, its President of Health & Biosciences, will leave the company on March 31, 2025, and that his departure qualifies under the company's executive severance policy. Leticia Goncalves Lourenço will join as President of the Health & Biosciences division effective March 1, 2025, so the division will have a successor in place before Herriott's exit.

Key points

  • Simon Herriott, President, Health & Biosciences, leaves IFF on March 31, 2025
  • His departure is treated as a qualifying event under IFF's executive severance policy
  • Leticia Goncalves Lourenço joins IFF as President, Health & Biosciences, effective March 1, 2025

The filing

CompanyInternational Flavors & Fragrances (IFF)
Form8-K, current report
Filed with the SECFeb 20, 2025, 4:49 PM ET
Accession number0001193125-25-030788

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 20, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.